These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2846508)

  • 21. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis.
    Thakur CP; Kumar K
    Indian J Med Res; 1990 Mar; 91():144-8. PubMed ID: 2160914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1985 May; 33(5):379-80. PubMed ID: 2995305
    [No Abstract]   [Full Text] [Related]  

  • 24. B lymphocyte population and immunoglobulins in Indian kala-azar in response to chemotherapy.
    Neogy AB; Nandy A; Dastidar BG; Chowdhury AB
    Acta Trop; 1986 Sep; 43(3):237-44. PubMed ID: 2877550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases.
    Thakur CP; Sinha GP; Pandey AK; Kumar N; Kumar P; Hassan SM; Narain S; Roy RK
    Ann Trop Med Parasitol; 1998 Jul; 92(5):561-9. PubMed ID: 9797829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient.
    Donovan KL; White AD; Cooke DA; Fisher DJ
    J Infect; 1990 Jul; 21(1):107-10. PubMed ID: 2166765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 28. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 29. Kala-azar in Madras city.
    Santhanakrishnan BR; Ramachandran A; Raju B
    Indian Pediatr; 1977 Jun; 14(6):471-3. PubMed ID: 203529
    [No Abstract]   [Full Text] [Related]  

  • 30. Ketoconazole in antimonial unresponsive cases of Kala-azar.
    Jha TK; Singh NK; Jha S
    J Assoc Physicians India; 1995 May; 43(5):347. PubMed ID: 9081966
    [No Abstract]   [Full Text] [Related]  

  • 31. Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya.
    Rashid JR; Chunge CN; Oster CN; Wasunna KM; Muigai R; Gachihi GS
    East Afr Med J; 1986 May; 63(5):365-71. PubMed ID: 3017678
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.
    Thakur CP; Kumar K; Sinha PK; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1987 Oct; 295(6603):886-7. PubMed ID: 2823955
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine.
    Thakur CP; Kumar A; Mitra G; Thakur S; Thakur M
    Indian J Med Res; 2007 Jul; 126(1):73-5. PubMed ID: 17890828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute renal failure and 9th, 10th nerve palsy in patient of kala-azar treated with stibanate.
    Rai US; Kumar H; Kumar U; Amitabh V
    J Assoc Physicians India; 1994 Apr; 42(4):338. PubMed ID: 7860562
    [No Abstract]   [Full Text] [Related]  

  • 36. A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate.
    Sundar S; Sinha PR; Agrawal NK; Srivastava R; Rainey PM; Berman JD; Murray HW; Singh VP
    Am J Trop Med Hyg; 1998 Jul; 59(1):139-43. PubMed ID: 9684642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1987 Sep; 35(9):641-3. PubMed ID: 2830224
    [No Abstract]   [Full Text] [Related]  

  • 38. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of leishmaniasis with sodium antimony gluconate: transient ECG findings.
    Kaplan RJ; Wilkin JK; Hartman DL
    South Med J; 1978 Apr; 71(4):469-70. PubMed ID: 205001
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kala-azar--an endemic disease close to Switzerland. Apropos of 2 cases in children observed in Geneva].
    Thélin O
    Rev Med Suisse Romande; 1985 Apr; 105(4):363-8. PubMed ID: 2990003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.